Your browser doesn't support javascript.
loading
Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement.
Pickering, Justin; Wong, Rachel; Al-Salami, Hani; Lam, Virginie; Takechi, Ryu.
Afiliación
  • Pickering J; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, WA, 6845, Australia.
  • Wong R; Institute for Resilient Regions, University of Southern Queensland, Springfield Central, QLD, 4300, Australia.
  • Al-Salami H; Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, 6845, Australia.
  • Lam V; Curtin Health Innovation Research Institute, Curtin University, Perth, WA, 6845, Australia.
  • Takechi R; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, WA, 6845, Australia.
Pharm Res ; 38(9): 1477-1484, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34480263
The evidence shows that individuals with type-1 diabetes mellitus (T1DM) are at greater risk of accelerated cognitive impairment and dementia. Although, to date the mechanisms are largely unknown. An emerging body of literature indicates that dysfunction of cerebral neurovascular network and plasma dyshomeostasis of soluble amyloid-ß in association with impaired lipid metabolism are central to the onset and progression of cognitive deficits and dementia. However, the latter has not been extensively considered in T1DM. Therefore, in this review, we summarised the literature concerning altered lipid metabolism and cerebrovascular function in T1DM as an implication for potential pathways leading to cognitive decline and dementia.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Cerebrovasculares / Diabetes Mellitus Tipo 1 / Disfunción Cognitiva / Glucosa Límite: Animals / Humans Idioma: En Revista: Pharm Res Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Cerebrovasculares / Diabetes Mellitus Tipo 1 / Disfunción Cognitiva / Glucosa Límite: Animals / Humans Idioma: En Revista: Pharm Res Año: 2021 Tipo del documento: Article País de afiliación: Australia